March 5, 2021

WHO stops hydroxychloroquine trials to detect higher mortality

The director general of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, announced today that the body will temporarily stop clinical trials with hydroxychloroquine in COVID-19 patients, as a higher mortality rate has been detected in these patients.

The decision, a precautionary measure that could be revised, has been made after the publication last Friday in the medical journal The Lancet of a study that indicated higher mortality rates in patients who had tried hydroxychloroquine treatments. , commonly used against malaria.

The precautionary measure, which could affect countries like Brazil (who last week had approved the widespread use of hydroxychloroquine in COVID-19 patients) does not in principle apply to chloroquine, of which the former is a derivative and that it is also included in WHO clinical trials.


Source link